INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study
Part of paid clinical trials in Jacksonville, Florida.
- Sponsor
- Synchron, Inc.
- Study ID
- NCT07543367
- Status
- Recruiting
Conditions
- ALS
- ALS (Amyotrophic Lateral Sclerosis)
- ALS - Amyotrophic Lateral Sclerosis
- Motor Neuron Disease
- Neurological Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 22 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Stentrode — DEVICEThe Stentrode is an endovascular electrode array that senses electrical signals from the sensorimotor cortices.
Study Details
INdependence Through Endovascular Neuroprosthetic Technology (INTENT): an Early Feasibility Study
Key Dates
- Start date
- Apr 30, 2026
- Status verified
- May 2026
- Primary completion
- Jun 30, 2027
- Completion
- Dec 31, 2029
Study Design
- Enrollment
- 10 participants (estimated)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- OTHER
Arms
- Other: Single ArmDevice: Stentrode
Primary Outcome Measure
Device-related serious adverse events up to 180 days after implant [ Time Frame: 6 Months ]
Locations (5)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Mayo Clinic | Jacksonville | Florida | 32224 | Bjorn Oskarsson, MD (PRINCIPAL_INVESTIGATOR) |
| University of Buffalo Neurosurgery | Buffalo | New York | 14203 | Elad Levy, MD (PRINCIPAL_INVESTIGATOR) |
| Mount Sinai Hospital | New York | New York | 10029 | Shahram Majidi, MD (PRINCIPAL_INVESTIGATOR) |
| University of Pittsburgh Medical Center (UPMC) | Pittsburgh | Pennsylvania | 15213 | Jackie Krugh Raul Nogueira, MD (PRINCIPAL_INVESTIGATOR) |
| University of Texas Southwestern Medical Center (UTSW) | Dallas | Texas | 75390 | Tashinga (Tash) Mupambo Babu Welch, MD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Jacksonville, FL
Related Studies
- Neurologic Stem Cell Treatment StudyRecruiting · MD Stem Cells · Westport, Connecticut
- Amyotrophic Lateral Sclerosis (ALS) Families ProjectRecruiting · Columbia University · New York, New York
- Target ALS Biomarker Study; Longitudinal Biofluids, Clinical Measures, and At Home MeasuresRecruiting · Target ALS Foundation, Inc. · Phoenix, Arizona
- Non-invasive BCI-controlled Assistive DevicesRecruiting · University of Texas at Austin · Austin, Texas